Dave Bradley

Dave Bradley currently serves as a Principal within Real Chemistry’s Analytics & Insights group. For more than fifteen years, Dave has supported the decision-making of his biopharmaceutical clients by teasing out actionable insights from deep data analysis. Working with clients across Europe and the US, Dave has developed a rich understanding of the data landscape, and he has leveraged this expertise to inform decisions across commercial and medical groups, from small pre-commercial biotechs to global pharmaceutical firms. Prior to his tenure with Real Chemistry, Dave spent over a decade at ZS Associates, where he helped build out the Rare Disease practice. Since joining Real Chemistry, he has extended his focus from rare disease to also include extensive work in oncology. Dave studied natural sciences, with a specialization in Chemistry, at the University of Cambridge.